Haploidentical Transplantation for AML Patients With Minimal/ Measurable Residual Disease at Transplantation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
American Journal of Hematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Haploidentical Transplantation for Acute Myeloid Leukemia Patients With Minimal/ Measurable Residual Disease at Transplantation
Am. J. Hematol 2019 Oct 08;[EPub Ahead of Print], SA Srour, RM Saliba, MC Bittencourt, JM Ramos Perez, P Kongtim, A Alousi, G Al-Atrash, A Olson, O Betul, R Mehta, U Popat, C Hosing, Q Bashir, I Khouri, P Kebriaei, L Masarova, N Short, E Jabbour, N Daver, M Konopleva, F Ravandi, H Kantarjian, RE Champlin, SO CiureaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.